OptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes,
OptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes,
OptiBiotix Health plc (AIM: OPTI), a life sciences company focused on products that reduce hunger and food cravings, improve the gut microbiome, and offer sweet fibres as healthy sugar alternatives,
New SlimBiome® study published in European Journal of Nutrition
First order from leading US weight management brand
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes, provides the
Launch of Daily Nouri FeelFull product in America SlimBiome® containing finished products
OptiBiotix Health plc (AIM: OPTI) (“OptiBiotix”) the life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skincare, advises that in relation to the requisitioned general meeting of
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skincare, announces further positive study results.
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skincare, announces that it has reached agreement to launch its own brands
OPTI shares have soared in July. Is it too late to get in, or is the company just getting started?
Launch of GoFigure products on Tmall China
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, cardiovascular diseaseanddiabetes, provides the following unaudited trading update ahead of the Group’s half year results for